je.st
news
Apricus Biosciences Announces $11 Million Registered Direct Offering...
2015-02-11 18:30:32| Biotech - Topix.net
Apricus Biosciences, Inc. , a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has entered into definitive agreements with affiliates of Sarissa Capital Management LP and an additional accredited investor, in a registered direct offering of 6,043,955 shares of common stock and warrants to purchase up to 3,021,977 shares of common stock. The shares and warrants are being sold in combination, consisting of one share of common stock and a warrant to purchase .50 of a share of common stock, at an offering price of $1.82 for expected gross proceeds of approximately $11.0 million.
Tags: registered
direct
million
offering
Category:Biotechnology and Pharmaceuticals